List of Tables
Table 1. Global Nanobody Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nanobody Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nanobody Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nanobody Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nanobody Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nanobody Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nanobody Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nanobody Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nanobody Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nanobody Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nanobody Drug, Product Type & Application
Table 12. Global Key Manufacturers of Nanobody Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nanobody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobody Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nanobody Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nanobody Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Nanobody Drug Sales Market Share by Region (2020-2025)
Table 19. Global Nanobody Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Nanobody Drug Sales Market Share by Region (2026-2031)
Table 21. Global Nanobody Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nanobody Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Nanobody Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nanobody Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Nanobody Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nanobody Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Nanobody Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Nanobody Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nanobody Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nanobody Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nanobody Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nanobody Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nanobody Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nanobody Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nanobody Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nanobody Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nanobody Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nanobody Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nanobody Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nanobody Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nanobody Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nanobody Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nanobody Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nanobody Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nanobody Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nanobody Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nanobody Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nanobody Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nanobody Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nanobody Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Nanobody Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Nanobody Drug Sales Market Share by Type (2020-2025)
Table 53. Global Nanobody Drug Sales Market Share by Type (2026-2031)
Table 54. Global Nanobody Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nanobody Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nanobody Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Nanobody Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Nanobody Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nanobody Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nanobody Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Nanobody Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Nanobody Drug Sales Market Share by Application (2020-2025)
Table 63. Global Nanobody Drug Sales Market Share by Application (2026-2031)
Table 64. Global Nanobody Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nanobody Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nanobody Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Nanobody Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Nanobody Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nanobody Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim Nanobody Drug Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Sanofi Company(Ablynx) Company Information
Table 76. Sanofi Company(Ablynx) Description and Business Overview
Table 77. Sanofi Company(Ablynx) Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Company(Ablynx) Nanobody Drug Product
Table 79. Sanofi Company(Ablynx) Recent Developments/Updates
Table 80. Merck KGaA Company Information
Table 81. Merck KGaA Description and Business Overview
Table 82. Merck KGaA Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck KGaA Nanobody Drug Product
Table 84. Merck KGaA Recent Developments/Updates
Table 85. Jerry Corning Company Information
Table 86. Jerry Corning Description and Business Overview
Table 87. Jerry Corning Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Jerry Corning Nanobody Drug Product
Table 89. Jerry Corning Recent Developments/Updates
Table 90. Shenzhen Pregene Biopharma Co Company Information
Table 91. Shenzhen Pregene Biopharma Co Description and Business Overview
Table 92. Shenzhen Pregene Biopharma Co Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Shenzhen Pregene Biopharma Co Nanobody Drug Product
Table 94. Shenzhen Pregene Biopharma Co Recent Developments/Updates
Table 95. Novamab Company Information
Table 96. Novamab Description and Business Overview
Table 97. Novamab Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novamab Nanobody Drug Product
Table 99. Novamab Recent Developments/Updates
Table 100. PersonGen Company Information
Table 101. PersonGen Description and Business Overview
Table 102. PersonGen Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PersonGen Nanobody Drug Product
Table 104. PersonGen Recent Developments/Updates
Table 105. Nanjing Legend Biotechnology Co., Ltd. Company Information
Table 106. Nanjing Legend Biotechnology Co., Ltd. Description and Business Overview
Table 107. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product
Table 109. Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
Table 110. Taiwan Taisho Pharmaceutical Company Information
Table 111. Taiwan Taisho Pharmaceutical Description and Business Overview
Table 112. Taiwan Taisho Pharmaceutical Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Taiwan Taisho Pharmaceutical Nanobody Drug Product
Table 114. Taiwan Taisho Pharmaceutical Recent Developments/Updates
Table 115. Yiteng Pharmaceutical Company Information
Table 116. Yiteng Pharmaceutical Description and Business Overview
Table 117. Yiteng Pharmaceutical Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Yiteng Pharmaceutical Nanobody Drug Product
Table 119. Yiteng Pharmaceutical Recent Developments/Updates
Table 120. Beijing Shuoxing Biotechnology Company Information
Table 121. Beijing Shuoxing Biotechnology Description and Business Overview
Table 122. Beijing Shuoxing Biotechnology Nanobody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Beijing Shuoxing Biotechnology Nanobody Drug Product
Table 124. Beijing Shuoxing Biotechnology Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Nanobody Drug Distributors List
Table 128. Nanobody Drug Customers List
Table 129. Nanobody Drug Market Trends
Table 130. Nanobody Drug Market Drivers
Table 131. Nanobody Drug Market Challenges
Table 132. Nanobody Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nanobody Drug
Figure 2. Global Nanobody Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanobody Drug Market Share by Type: 2024 & 2031
Figure 4. Monovalent Nanobodies Product Picture
Figure 5. Multivalent Nanobodies Product Picture
Figure 6. Fusion Nanobodies Product Picture
Figure 7. Others Product Picture
Figure 8. Global Nanobody Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Nanobody Drug Market Share by Application: 2024 & 2031
Figure 10. Tumor Treatment
Figure 11. Immune Disease Treatment
Figure 12. Inflammatory Disease Treatment
Figure 13. Others
Figure 14. Global Nanobody Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Nanobody Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Nanobody Drug Sales (2020-2031) & (K Units)
Figure 17. Global Nanobody Drug Average Price (US$/Unit) & (2020-2031)
Figure 18. Nanobody Drug Report Years Considered
Figure 19. Nanobody Drug Sales Share by Manufacturers in 2024
Figure 20. Global Nanobody Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Nanobody Drug Players: Market Share by Revenue in Nanobody Drug in 2024
Figure 22. Nanobody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Nanobody Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Nanobody Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Nanobody Drug Revenue Market Share by Country (2020-2031)
Figure 26. United States Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Nanobody Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Nanobody Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Nanobody Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Nanobody Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Nanobody Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Nanobody Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Nanobody Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Nanobody Drug Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Nanobody Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Nanobody Drug by Type (2020-2031)
Figure 56. Global Revenue Market Share of Nanobody Drug by Type (2020-2031)
Figure 57. Global Nanobody Drug Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Nanobody Drug by Application (2020-2031)
Figure 59. Global Revenue Market Share of Nanobody Drug by Application (2020-2031)
Figure 60. Global Nanobody Drug Price (US$/Unit) by Application (2020-2031)
Figure 61. Nanobody Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
